Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Orally Disintegrating Tablet (ODT) Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Orally Disintegrating Tablet (ODT) Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Anti-Psychotics Drug
      • 1.3.3 Anti-Epileptics Drug
      • 1.3.4 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Orally Disintegrating Tablet (ODT) Market Share by Application (2019-2025)
      • 1.4.2 CNS Diseases
      • 1.4.3 Gastrointestinal Diseases
      • 1.4.4 CVS Diseases
      • 1.4.5 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Orally Disintegrating Tablet (ODT) Market Size
      • 2.1.1 Global Orally Disintegrating Tablet (ODT) Revenue 2014-2025
      • 2.1.2 Global Orally Disintegrating Tablet (ODT) Sales 2014-2025
    • 2.2 Orally Disintegrating Tablet (ODT) Growth Rate by Regions
      • 2.2.1 Global Orally Disintegrating Tablet (ODT) Sales by Regions 2014-2019
      • 2.2.2 Global Orally Disintegrating Tablet (ODT) Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Orally Disintegrating Tablet (ODT) Sales by Manufacturers
      • 3.1.1 Orally Disintegrating Tablet (ODT) Sales by Manufacturers 2014-2019
      • 3.1.2 Orally Disintegrating Tablet (ODT) Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Orally Disintegrating Tablet (ODT) Revenue by Manufacturers (2014-2019)
      • 3.2.2 Orally Disintegrating Tablet (ODT) Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Orally Disintegrating Tablet (ODT) Market Concentration Ratio (CR5 and HHI)
    • 3.3 Orally Disintegrating Tablet (ODT) Price by Manufacturers
    • 3.4 Key Manufacturers Orally Disintegrating Tablet (ODT) Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Orally Disintegrating Tablet (ODT) Market
    • 3.6 Key Manufacturers Orally Disintegrating Tablet (ODT) Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Anti-Psychotics Drug Sales and Revenue (2014-2019)
      • 4.1.2 Anti-Epileptics Drug Sales and Revenue (2014-2019)
      • 4.1.3 Other Sales and Revenue (2014-2019)
    • 4.2 Global Orally Disintegrating Tablet (ODT) Sales Market Share by Type
    • 4.3 Global Orally Disintegrating Tablet (ODT) Revenue Market Share by Type
    • 4.4 Orally Disintegrating Tablet (ODT) Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Orally Disintegrating Tablet (ODT) Sales by Application

    6 United States

    • 6.1 United States Orally Disintegrating Tablet (ODT) Breakdown Data by Company
    • 6.2 United States Orally Disintegrating Tablet (ODT) Breakdown Data by Type
    • 6.3 United States Orally Disintegrating Tablet (ODT) Breakdown Data by Application

    7 European Union

    • 7.1 European Union Orally Disintegrating Tablet (ODT) Breakdown Data by Company
    • 7.2 European Union Orally Disintegrating Tablet (ODT) Breakdown Data by Type
    • 7.3 European Union Orally Disintegrating Tablet (ODT) Breakdown Data by Application

    8 China

    • 8.1 China Orally Disintegrating Tablet (ODT) Breakdown Data by Company
    • 8.2 China Orally Disintegrating Tablet (ODT) Breakdown Data by Type
    • 8.3 China Orally Disintegrating Tablet (ODT) Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Orally Disintegrating Tablet (ODT) Breakdown Data by Company
    • 9.2 Rest of World Orally Disintegrating Tablet (ODT) Breakdown Data by Type
    • 9.3 Rest of World Orally Disintegrating Tablet (ODT) Breakdown Data by Application
    • 9.4 Rest of World Orally Disintegrating Tablet (ODT) Breakdown Data by Countries
      • 9.4.1 Rest of World Orally Disintegrating Tablet (ODT) Sales by Countries
      • 9.4.2 Rest of World Orally Disintegrating Tablet (ODT) Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Teva
      • 10.1.1 Teva Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.1.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.1.5 Teva Recent Development
    • 10.2 Merck
      • 10.2.1 Merck Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.2.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.2.5 Merck Recent Development
    • 10.3 Mylan
      • 10.3.1 Mylan Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.3.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.3.5 Mylan Recent Development
    • 10.4 Pfizer
      • 10.4.1 Pfizer Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.4.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.4.5 Pfizer Recent Development
    • 10.5 Johnson and Johnson
      • 10.5.1 Johnson and Johnson Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.5.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.5.5 Johnson and Johnson Recent Development
    • 10.6 GSK
      • 10.6.1 GSK Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.6.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.6.5 GSK Recent Development
    • 10.7 Otsuka
      • 10.7.1 Otsuka Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.7.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.7.5 Otsuka Recent Development
    • 10.8 Eli Lilly and Company
      • 10.8.1 Eli Lilly and Company Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.8.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.8.5 Eli Lilly and Company Recent Development
    • 10.9 AstraZeneca
      • 10.9.1 AstraZeneca Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.9.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.9.5 AstraZeneca Recent Development
    • 10.10 Bristol-Myers Squibb
      • 10.10.1 Bristol-Myers Squibb Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Orally Disintegrating Tablet (ODT)
      • 10.10.4 Orally Disintegrating Tablet (ODT) Product Introduction
      • 10.10.5 Bristol-Myers Squibb Recent Development
    • 10.11 Conquer

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Orally Disintegrating Tablet (ODT) Sales Channels
      • 11.2.2 Orally Disintegrating Tablet (ODT) Distributors
    • 11.3 Orally Disintegrating Tablet (ODT) Customers

    12 Market Forecast

    • 12.1 Global Orally Disintegrating Tablet (ODT) Sales and Revenue Forecast 2019-2025
    • 12.2 Global Orally Disintegrating Tablet (ODT) Sales Forecast by Type
    • 12.3 Global Orally Disintegrating Tablet (ODT) Sales Forecast by Application
    • 12.4 Orally Disintegrating Tablet (ODT) Forecast by Regions
      • 12.4.1 Global Orally Disintegrating Tablet (ODT) Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Orally Disintegrating Tablet (ODT) Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
      In 2019, the market size of Orally Disintegrating Tablet (ODT) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Orally Disintegrating Tablet (ODT).

      This report studies the global market size of Orally Disintegrating Tablet (ODT), especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Orally Disintegrating Tablet (ODT) sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Teva
      Merck
      Mylan
      Pfizer
      Johnson and Johnson
      GSK
      Otsuka
      Eli Lilly and Company
      AstraZeneca
      Bristol-Myers Squibb
      Conquer

      Market Segment by Product Type
      Anti-Psychotics Drug
      Anti-Epileptics Drug
      Other

      Market Segment by Application
      CNS Diseases
      Gastrointestinal Diseases
      CVS Diseases
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Orally Disintegrating Tablet (ODT) status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Orally Disintegrating Tablet (ODT) manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Orally Disintegrating Tablet (ODT) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now